Lucid Diagnostics (LUCD) EBITDA Margin (2021 - 2026)
Lucid Diagnostics' (LUCD) quarterly EBITDA Margin came in at 931.85% in Q1 2026, up 57625.0% YoY from N/an in Q1 2025, and little changed on a QoQ basis from 935.31% in Q4 2025.
Lucid Diagnostics (LUCD) EBITDA Margin (2021 - 2026) Analysis & Trends
Lucid Diagnostics (LUCD) has 6 years of EBITDA Margin data on file, last reported at 931.85% in Q1 2026.
- Quarterly EBITDA Margin rose 57625.0% year-over-year to 931.85% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 945.82% (up 19839.0% YoY) and the FY2025 annual result came in at 1056.17%, up 347.0% from the prior year.
- EBITDA Margin held at 931.85% in Q1 2026, from 935.31% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 931.85% in Q1 2026 to a low of 18917.11% in Q3 2022.
- A 5-year average of 3834.36% and a median of 1123.99% in 2023 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2022 — EBITDA Margin sank 1566211 bps — and 2023, when it surged 1749590 bps.
- Tracing LUCD's EBITDA Margin over 5 years: stood at 13370.54% in 2022, then surged by 92 bps to 1101.25% in 2023, then rose by 6 bps to 1033.83% in 2024, then advanced by 10 bps to 935.31% in 2025, then climbed by 0 bps to 931.85% in 2026.
- The last three EBITDA Margin figures came in at 931.85% (Q1 2026), 935.31% (Q4 2025), and 971.02% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.61 Bn | 194.01 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 127.81 Bn | 124.34 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 119.04 Bn | 109.82 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 73.68 Bn | 73.14 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 51.96 Bn | 47.71 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.36 Bn | 32.41 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 33.83 Bn | 31.72 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.06 Bn | 22.58 Bn | 684.20 Mn | 19.15% |
| 10 | Lucid Diagnostics | 176.81 Mn | 143.40 Mn | 55,000.00 | -853.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -853.40% |
| Mar 31, 2026 | -931.85% |
| Dec 31, 2025 | -935.31% |
| Sep 30, 2025 | -971.02% |
| Jun 30, 2025 | -948.67% |
| Mar 31, 2025 | -1,508.09% |
| Dec 31, 2024 | -1,033.83% |
| Sep 30, 2024 | -997.78% |
| Jun 30, 2024 | -1,146.72% |
| Mar 31, 2024 | -1,078.12% |
| Dec 31, 2023 | -1,101.25% |
| Sep 30, 2023 | -1,421.20% |
| Jun 30, 2023 | -7,285.53% |
| Mar 31, 2023 | -3,210.09% |
| Dec 31, 2022 | -13,370.54% |
| Sep 30, 2022 | -18,917.11% |
| Mar 31, 2022 | -6,492.59% |
| Dec 31, 2021 | -3,747.00% |
| Sep 30, 2021 | -3,255.00% |